Novo Holdings A/S
Source: SEC Form 13F · as of Mar 2026Novo Holdings A/S holds 10 biotech & pharma companies tracked by BioSniper, totaling $430.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$430.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for MapLight Therapeutics, Inc. (MPLT)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| MPLTMapLight Therapeutics, Inc. | 3,686,622 | $74.9M |
| ELVNEnliven Therapeutics, Inc. | 1,280,000 | $50.2M |
| PCVXVaxcyte, Inc. | 860,000 | $50.0M |
| PHVSPharvaris N.V. | 1,750,000 | $49.4M |
| VRDNViridian Therapeutics, Inc.\DE | 2,000,000 | $39.1M |
| CLDXCelldex Therapeutics, Inc. | 1,200,000 | $38.1M |
| APGEApogee Therapeutics, Inc. | 450,000 | $37.9M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 660,000 | $37.3M |
| FDMT4D Molecular Therapeutics, Inc. | 3,650,737 | $34.0M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 2,185,923 | $19.6M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.